BORTEZOMIB EVER PHARMA 2,5 mg/mL, solution injectable — 1 flacon(s) en verre de 1,4 mL (3,5 mg/1,4 mL)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930243695
  • CIP7 3024369
  • CIS 65491006

What the source publishes

Holder
EVER VALINJECT (AUTRICHE)
Active ingredients
ESTER BORONIQUE DE MANNITOL, BORTÉZOMIB
Form
solution injectable
Package
1 flacon(s) en verre de 1,4 mL (3,5 mg/1,4 mL)
Routes
intraveineuse, sous-cutanée
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2021-12-14
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930243695
{
  "cis": "65491006",
  "cip7": "3024369",
  "form": "solution injectable",
  "name": "BORTEZOMIB EVER PHARMA 2,5 mg/mL, solution injectable — 1 flacon(s) en verre de 1,4 mL (3,5 mg/1,4 mL)",
  "cip13": "3400930243695",
  "holder": "EVER VALINJECT (AUTRICHE)",
  "routes": [
    "intraveineuse",
    "sous-cutanée"
  ],
  "holders": [
    "EVER VALINJECT (AUTRICHE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2021-12-14",
  "compositions": [
    {
      "name": "ESTER BORONIQUE DE MANNITOL",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "60273",
      "dosageReference": null,
      "pharmaceuticalElement": "solution"
    },
    {
      "name": "BORTÉZOMIB",
      "nature": "FT",
      "strength": "2,5 mg",
      "linkageNumber": "1",
      "substanceCode": "98525",
      "dosageReference": "1 mL de solution injectable",
      "pharmaceuticalElement": "solution"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "BORTEZOMIB EVER PHARMA 2,5 mg/mL, solution injectable",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "1 flacon(s) en verre de 1,4 mL (3,5 mg/1,4 mL)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2022-04-07",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ESTER BORONIQUE DE MANNITOL",
    "BORTÉZOMIB"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930243695"